UNSPSC 51391721: Fenoterol

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C17H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22M9P70OQ9, chemically known as 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol but generally known as fenoterol, which bears US NIH Compound Identifier 3343. European Medicines Agency schedules Fenoterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07579MIG.

UNSPSC 51391721 Fenoterol is a Commodity code that reflects state and local procurement of pharmaceutical products and related medical-device systems supporting emergency response and community health initiatives. The recent activity under this code shows state and local governments purchasing naloxone (an opioid-reversal agent) and drug deactivation systems in bulk quantities for distribution through public health and emergency-services programs. These purchases typically include annual unit commitments with scheduled deliveries to designated public facilities, coupled with compliance requirements such as E-Verify authorization, drug-free workplace certification, and insurance coverage mandates.

Seminole County, Florida has posted the most recent opportunity under this code—an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The county structured the procurement with an initial two-year term and one-year renewal option, fixed pricing on a per-unit basis, and a three-month probationary termination clause. FEMA funding was identified as a potential source, introducing federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence. Beyond this single recent solicitation, the source identifies no other state or local opportunities under this code, suggesting limited current market activity for fenoterol or closely related pharmaceutical commodities at the state and local level.